0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-18X6955
Home | Market Reports | Health | Health Conditions | Cancer
China Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Report Forecast 2021 2027

China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Report & Forecast 2021-2027

Code: QYRE-Auto-18X6955
Report
October 2021
108 Pages
QYResearch
Region: China,
Description
Table of Content
Tables & Figures
This report contains market size and forecasts of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in China, including the following market information:
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Sales, 2016-2021, 2022-2027, (M Units)
China top five Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs companies in 2020 (%)

The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size is expected to growth from US$ 2328 million in 2020 to US$ 2139.8 million by 2027; it is expected to grow at a CAGR of -1.6% during 2021-2027.

The China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segment Percentages, By Type, 2020 (%)
5-HT3 Inhibitors
NK1 Inhibitors
Others
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)
China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segment Percentages, By Application, 2020 (%)
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs revenues share in China market, 2020 (%)
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales in China market, 2016-2021 (Estimated), (M Units)
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
1 Introduction to Research & Analysis Reports
1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Overall Market Size
2.1 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size: 2021 VS 2027
2.2 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players in China Market
3.2 Top China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies Ranked by Revenue
3.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Companies
3.4 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Companies
3.5 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players in China Market
3.8.1 List of Tier 1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Markets, 2021 & 2027
4.1.2 5-HT3 Inhibitors
4.1.3 NK1 Inhibitors
4.1.4 Others
4.2 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue & Forecasts
4.2.1 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2016-2021
4.2.2 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2022-2027
4.2.3 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2016-2027
4.3 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales & Forecasts
4.3.1 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2016-2021
4.3.2 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2022-2027
4.3.3 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2016-2027
4.4 By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2021 & 2027
5.1.2 Acute CINV
5.1.3 Delayed CINV
5.1.4 Breakthrough CINV
5.1.5 Others
5.2 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue & Forecasts
5.2.1 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2016-2021
5.2.2 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2022-2027
5.2.3 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2016-2027
5.3 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales & Forecasts
5.3.1 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2016-2021
5.3.2 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2022-2027
5.3.3 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2016-2027
5.4 By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Heron Therapeutics
6.1.1 Heron Therapeutics Corporation Information
6.1.2 Heron Therapeutics Overview
6.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.1.5 Heron Therapeutics Recent Developments
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Overview
6.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.2.5 Merck Recent Developments
6.3 Eisai
6.3.1 Eisai Corporation Information
6.3.2 Eisai Overview
6.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.3.5 Eisai Recent Developments
6.4 Mundipharma
6.4.1 Mundipharma Corporation Information
6.4.2 Mundipharma Overview
6.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.4.5 Mundipharma Recent Developments
6.5 Qilu Pharma
6.5.1 Qilu Pharma Corporation Information
6.5.2 Qilu Pharma Overview
6.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.5.5 Qilu Pharma Recent Developments
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Overview
6.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.6.5 Teva Recent Developments
6.7 Novartis
6.7.1 Novartis Corporation Information
6.7.2 Novartis Overview
6.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.7.5 Novartis Recent Developments
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Overview
6.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.8.5 Roche Recent Developments
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Overview
6.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.9.5 Mylan Recent Developments
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Overview
6.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.10.5 Baxter Recent Developments
6.11 GSK
6.11.1 GSK Corporation Information
6.11.2 GSK Overview
6.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.11.5 GSK Recent Developments
6.12 Helsinn
6.12.1 Helsinn Corporation Information
6.12.2 Helsinn Overview
6.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.12.5 Helsinn Recent Developments
6.13 Southwest Pharma
6.13.1 Southwest Pharma Corporation Information
6.13.2 Southwest Pharma Overview
6.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.13.5 Southwest Pharma Recent Developments
6.14 Haisco
6.14.1 Haisco Corporation Information
6.14.2 Haisco Overview
6.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.14.5 Haisco Recent Developments
6.15 Sun Pharma
6.15.1 Sun Pharma Corporation Information
6.15.2 Sun Pharma Overview
6.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in China Market (2016-2021)
6.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Description
6.15.5 Sun Pharma Recent Developments
7 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity, Analysis
7.1 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity, 2016-2027
7.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Supply Chain Analysis
9.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Value Chain
9.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Upstream Market
9.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
    Table 1. Key Players of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in China Market
    Table 2. Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players in China Market, Ranking by Revenue (2019)
    Table 3. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Companies, 2016-2021
    Table 5. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Companies, (M Units), 2016-2021
    Table 6. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (2016-2021) & (US$/Unit)
    Table 8. Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
    Table 9. List of Tier 1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. Major Manufacturers of 5-HT3 Inhibitors
    Table 12. Major Manufacturers of NK1 Inhibitors
    Table 13. By Type – China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2021 & 2027
    Table 14. By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2016-2021
    Table 15. By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2022-2027
    Table 16. By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2016-2021
    Table 17. By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2022-2027
    Table 18. By Application – China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 19. By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2016-2021
    Table 20. By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2022-2027
    Table 21. By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2016-2021
    Table 22. By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2022-2027
    Table 23. Heron Therapeutics Corporation Information
    Table 24. Heron Therapeutics Description and Major Businesses
    Table 25. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 26. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 27. Heron Therapeutics Recent Developments
    Table 28. Merck Corporation Information
    Table 29. Merck Description and Major Businesses
    Table 30. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 31. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 32. Merck Recent Developments
    Table 33. Eisai Corporation Information
    Table 34. Eisai Description and Major Businesses
    Table 35. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 36. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 37. Eisai Recent Developments
    Table 38. Mundipharma Corporation Information
    Table 39. Mundipharma Description and Major Businesses
    Table 40. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 41. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 42. Mundipharma Recent Developments
    Table 43. Qilu Pharma Corporation Information
    Table 44. Qilu Pharma Description and Major Businesses
    Table 45. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 46. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 47. Qilu Pharma Recent Developments
    Table 48. Teva Corporation Information
    Table 49. Teva Description and Major Businesses
    Table 50. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 51. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 52. Teva Recent Developments
    Table 53. Novartis Corporation Information
    Table 54. Novartis Description and Major Businesses
    Table 55. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 56. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 57. Novartis Recent Developments
    Table 58. Roche Corporation Information
    Table 59. Roche Description and Major Businesses
    Table 60. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 61. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 62. Roche Recent Developments
    Table 63. Mylan Corporation Information
    Table 64. Mylan Description and Major Businesses
    Table 65. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 66. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 67. Mylan Recent Developments
    Table 68. Baxter Corporation Information
    Table 69. Baxter Description and Major Businesses
    Table 70. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 71. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 72. Baxter Recent Developments
    Table 73. GSK Corporation Information
    Table 74. GSK Description and Major Businesses
    Table 75. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 76. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 77. GSK Recent Developments
    Table 78. Helsinn Corporation Information
    Table 79. Helsinn Description and Major Businesses
    Table 80. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 81. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 82. Helsinn Recent Developments
    Table 83. Southwest Pharma Corporation Information
    Table 84. Southwest Pharma Description and Major Businesses
    Table 85. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 86. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 87. Southwest Pharma Recent Developments
    Table 88. Haisco Corporation Information
    Table 89. Haisco Description and Major Businesses
    Table 90. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 91. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 92. Haisco Recent Developments
    Table 93. Sun Pharma Corporation Information
    Table 94. Sun Pharma Description and Major Businesses
    Table 95. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 96. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
    Table 97. Sun Pharma Recent Developments
    Table 98. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity (M Units) of Key Manufacturers in China Market, 2019-2021 (M Units)
    Table 99. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Capacity Market Share of Key Manufacturers, 2019-2021
    Table 100. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Opportunities & Trends in China Market
    Table 101. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers in China Market
    Table 102. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints in China Market
    Table 103. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Materials
    Table 104. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Materials Suppliers in China Market
    Table 105. Typical Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Downstream
    Table 106. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Downstream Clients in China Market
    Table 107. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors and Sales Agents in China Market
List of Figures
    Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Picture
    Figure 2. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type
    Figure 3. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application
    Figure 4. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview: 2020
    Figure 5. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 7. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in China Market: 2016-2027 (M Units)
    Figure 8. The Top 3 and 5 Players Market Share by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue in 2020
    Figure 9. 5-HT3 Inhibitors Product Picture
    Figure 10. NK1 Inhibitors Product Picture
    Figure 11. Others Product Picture
    Figure 12. By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2016-2027
    Figure 13. By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2016-2027
    Figure 14. By Type - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit), 2016-2027
    Figure 15. Acute CINV
    Figure 16. Delayed CINV
    Figure 17. Breakthrough CINV
    Figure 18. Others
    Figure 19. By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2016-2027
    Figure 20. By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2016-2027
    Figure 21. By Application - China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit), 2016-2027
    Figure 22. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 27. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 28. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 29. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 30. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 31. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 32. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 33. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 34. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 35. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 36. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 37. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity (M Units), 2016-2027
    Figure 38. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Value Chain
    Figure 39. Marketing Channels
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global and Japan Prostate Cancer Vaccines Market Insights Forecast to 2027
Global and Japan Prostate Cancer Vaccines Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28J7570
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States Chemotherapy Infusion Set Market Insights Forecast to 2027
Global and United States Chemotherapy Infusion Set Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-25T7219
Sat Nov 20 00:00:00 UTC 2021

Add to Cart

Global and United States Cyclin Dependent Kinase 9 Market Insights Forecast to 2027
Global and United States Cyclin Dependent Kinase 9 Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-5Y7284
Tue Nov 02 00:00:00 UTC 2021

Add to Cart

Global and China Anaplastic Thyroid Cancer Drug Market Insights Forecast to 2027
Global and China Anaplastic Thyroid Cancer Drug Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-11G7330
Tue Nov 02 00:00:00 UTC 2021

Add to Cart